A detailed history of Wolverine Trading, LLC transactions in Grifols Sa stock. As of the latest transaction made, Wolverine Trading, LLC holds 11,900 shares of GRFS stock, worth $100,317. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,900
Holding current value
$100,317
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$5.47 - $11.38 $84,052 - $174,865
15,366 New
15,366 $102,000
Q3 2023

Nov 15, 2023

BUY
$8.91 - $10.91 $162,108 - $198,496
18,194 New
18,194 $166,000
Q4 2022

Feb 14, 2023

BUY
$5.96 - $8.53 $94,793 - $135,669
15,905 Added 145.28%
26,853 $228,000
Q3 2022

Nov 14, 2022

BUY
$5.95 - $14.3 $65,140 - $156,556
10,948 New
10,948 $65,000
Q2 2022

Aug 15, 2022

SELL
$10.6 - $13.28 $134,026 - $167,912
-12,644 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$10.37 - $12.73 $131,118 - $160,958
12,644 New
12,644 $149,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.72B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.